80
Participants
Start Date
January 20, 2020
Primary Completion Date
May 20, 2020
Study Completion Date
May 20, 2020
Pentraxin 3 ; new biomarker
"Pentraxin (PTX3) is an inflammatory molecule that belongs to a recently identified, well-known C-reactive protein (CRP) family.~PTX3 plasma levels increase in vascular disorders including myocardial infarction and correlate with small vessel vasculitis and outcome or disease activity.~These biological and clinical features of PTX3 have led us to investigate this molecule in preeclampsia, a syndrome characterized by a prominent vascular component."
Lipoprotein-associated phospholipase A2 ; new biomarker
Lp-PLA2 is a recently described and potentially useful plasma biomarker associated with cardiovascular diseases. Because of this effect, we will investigate that preeclampsia also be beneficial.
Kanuni Sultan Süleyman Training and Research Hospital, Istanbul
Kanuni Sultan Suleyman Training and Research Hospital
OTHER